Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advancing New Chemical Modalities into Clinical Studies
María‐Jesús Blanco, Kevin M. Gardinier, Mark Namchuk
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 11, pp. 1691-1698
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Beyond 20 in the 21st Century: Prospects and Challenges of Non-canonical Amino Acids in Peptide Drug Discovery
Jennifer L. Hickey, Dan Sindhikara, Susan L. Zultanski, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 5, pp. 557-565
Open Access | Times Cited: 70
Accelerating Drug Discovery: Synthesis of Complex Chemotypes via Multicomponent Reactions
Melissa J. Buskes, Aaron Coffin, Dawn M. Troast, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 4, pp. 376-385
Open Access | Times Cited: 44
Prodrugs as empowering tools in drug discovery and development: recent strategic applications of drug delivery solutions to mitigate challenges associated with lead compounds and drug candidates
Murugaiah A. M. Subbaiah, Jarkko Rautio, Nicholas A. Meanwell
Chemical Society Reviews (2024) Vol. 53, Iss. 4, pp. 2099-2210
Closed Access | Times Cited: 24
The rise of degrader drugs
Mingxing Teng, Nathanael S. Gray
Cell chemical biology (2023) Vol. 30, Iss. 8, pp. 864-878
Open Access | Times Cited: 27
Total Synthesis as Training for Medicinal Chemistry
Lewis D. Pennington
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 2, pp. 156-158
Closed Access | Times Cited: 6
Macrocyclization strategy for improving candidate profiles in medicinal chemistry
Om Darlami, R.Y.K. Pun, Sung‐Hoon Ahn, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116501-116501
Closed Access | Times Cited: 5
IMHB-Mediated Chameleonicity in Drug Design: A Focus on Structurally Related PROTACs
Diego García Jiménez, Matteo Rossi Sebastiano, Maura Vallaro, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 13, pp. 11421-11434
Closed Access | Times Cited: 5
Synthesis of tertiary alkylphosphonate oligonucleotides through light-driven radical-polar crossover reactions
Kenji Ota, Kazunori Nagao, Dai Hata, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Advances in Human Organs-on-Chips and Applications for Drug Screening and Personalized Medicine
Chenyang Zhou, Zhangjie Li, Kangyi Lu, et al.
Fundamental Research (2024)
Open Access | Times Cited: 4
Molecular properties, including chameleonicity, as essential tools for designing the next generation of oral beyond rule of five drugs
Giulia Caron, Diego García Jiménez, Maura Vallaro, et al.
ADMET & DMPK (2024)
Open Access | Times Cited: 3
New therapies on the horizon: Targeted protein degradation in neuroscience
James A Gregory, Christopher M. Hickey, Juan D. Chavez, et al.
Cell chemical biology (2024) Vol. 31, Iss. 9, pp. 1688-1698
Open Access | Times Cited: 2
DegraderTCM: A Computationally Sparing Approach for Predicting Ternary Degradation Complexes
Paolo Rossetti, Giulia Apprato, Giulia Caron, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 15, Iss. 1, pp. 45-53
Open Access | Times Cited: 7
Oral Absorption of Middle-to-Large Molecules and Its Improvement, with a Focus on New Modality Drugs
Daigo Asano, Hideo Takakusa, Daisuke Nakai
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 47-47
Open Access | Times Cited: 7
A Shift in Thinking: Cellular Thermal Shift Assay-Enabled Drug Discovery
Isabel Martín Caballero, Stina Lundgren
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 4, pp. 369-375
Closed Access | Times Cited: 6
Open Innovation and Regulatory Challenges in New Modality Development: The Pivotal Role of CDMOs in Advancing Antibody Drugs
Hiromu Yoshiura, Y. Kawata, Shintaro Sengoku
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
How should we teach medicinal chemistry in higher education to prepare students for a future career as medicinal chemists and drug designers? - A teacher´s perspective.
Philipp Klahn
(2024)
Open Access | Times Cited: 1
The Backbone Constitution Drives Passive Permeability Independent of Side Chains in Depsipeptide and Peptide Macrocycles Inspired by ent-Verticilide
Madelaine P. Thorpe, Abigail N. Smith, Daniel J. Blackwell, et al.
Chemical Science (2024) Vol. 15, Iss. 36, pp. 14977-14987
Open Access | Times Cited: 1
Allostery Illuminated: Harnessing AI and Machine Learning for Drug Discovery
María‐Jesús Blanco, Melissa J. Buskes, Rajiv Gandhi Govindaraj, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 9, pp. 1449-1455
Closed Access | Times Cited: 1
Open Innovation and Regulatory Challenges in New Modality Development: The Pivotal Role of Contract Development and Manufacturing Organisations in Advancing Antibody Drugs
Hiromu Yoshiura, Y. Kawata, Shintaro Sengoku
Therapeutic Innovation & Regulatory Science (2024)
Open Access | Times Cited: 1
How Should we Teach Medicinal Chemistry in Higher Education to Prepare Students for a Future Career as Medicinal Chemists and Drug Designers? – A Teacher's Perspective
Philipp Klahn
ChemMedChem (2024)
Open Access | Times Cited: 1
Why and How to Control P-Chirality in Phosphorothioated Therapeutic Oligonucleotides: Analytical Challenges Associated with Determination of Stereochemical Composition
Tanja Poredoš, Marko Trampuž, Tjaša Gornik, et al.
Organic Process Research & Development (2024)
Closed Access | Times Cited: 1
Understanding Intrinsic Warhead Reactivity and Cysteine Druggability in Covalent Drug Discovery
Chiara Borsari, Alexandra Ioana Corfu, Paola Conti
CHIMIA International Journal for Chemistry (2023) Vol. 77, Iss. 5, pp. 349-349
Open Access | Times Cited: 3
Recent trends in interorganizational deal networks in pharmaceutical and biotechnology industries
Kentaro Yashiro, Yeongjoo Lim, Shintaro Sengoku, et al.
Drug Discovery Today (2022) Vol. 28, Iss. 3, pp. 103483-103483
Open Access | Times Cited: 5
La Medicina Interna en la Gestión de Enfermedades Crónicas: Enfoque Clínico, Desafíos y Direcciones Futuras
María Rosa Urzola Suárez, Héctor Daniel Ayala Trujillo, Pamela Alejandra Sanmartín Jaramillo, et al.
Salud ConCiencia (2023) Vol. 2, Iss. 2, pp. e63-e63
Open Access | Times Cited: 2
Metabolism of new drug modalities research advances – 2023 year in review
Bin Ma, Upendra A. Argikar, Lionel Cheruzel, et al.
Drug Metabolism Reviews (2024), pp. 1-24
Closed Access
Page 1 - Next Page

Scroll to top